U.S. Physical Therapy, Inc.
USPH
$80.27
-$1.74-2.12%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 162.19M | 150.70M | 148.21M | 137.43M | 138.55M |
| Total Other Revenue | 33.16M | 31.24M | 30.39M | 28.89M | 26.92M |
| Total Revenue | 195.35M | 181.94M | 178.60M | 166.31M | 165.47M |
| Cost of Revenue | 147.92M | 145.09M | 127.97M | 133.75M | 126.67M |
| Gross Profit | 47.43M | 36.85M | 50.63M | 32.56M | 38.80M |
| SG&A Expenses | 17.48M | 16.25M | 15.57M | 14.39M | 14.25M |
| Depreciation & Amortization | 5.74M | 5.54M | 17.85M | -- | 4.30M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 171.13M | 166.88M | 161.40M | 148.13M | 145.22M |
| Operating Income | 24.22M | 15.06M | 17.20M | 18.18M | 20.26M |
| Income Before Tax | 22.65M | 17.33M | 18.32M | 12.34M | 14.80M |
| Income Tax Expenses | 4.93M | 3.86M | 5.83M | 2.56M | 3.08M |
| Earnings from Continuing Operations | 17.72M | 13.47M | 12.49M | 9.78M | 11.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -5.33M | -3.57M | -3.25M | -3.15M | -4.21M |
| Net Income | 12.39M | 9.90M | 9.24M | 6.63M | 7.51M |
| EBIT | 24.22M | 15.06M | 17.20M | 18.18M | 20.26M |
| EBITDA | 30.27M | 20.93M | 22.89M | 22.57M | 24.77M |
| EPS Basic | 0.58 | 0.80 | 0.52 | 0.39 | 0.47 |
| Normalized Basic EPS | 0.55 | 0.30 | 0.44 | 0.52 | 0.53 |
| EPS Diluted | 0.58 | 0.80 | 0.52 | 0.39 | 0.47 |
| Normalized Diluted EPS | 0.55 | 0.30 | 0.44 | 0.52 | 0.53 |
| Average Basic Shares Outstanding | 15.20M | 15.13M | 15.09M | 15.08M | 15.07M |
| Average Diluted Shares Outstanding | 15.20M | 15.13M | 15.09M | 15.08M | 15.07M |
| Dividend Per Share | 0.45 | 0.45 | 0.44 | 0.44 | 0.44 |
| Payout Ratio | 110.37% | -- | 71.85% | 100.09% | 176.71% |